Literature DB >> 593260

The pseudoirreversible inhibition of monoamine oxidase by allylamine.

R R Rando, A Eigner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 593260

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  4 in total

1.  Structural and mechanistic studies of mofegiline inhibition of recombinant human monoamine oxidase B.

Authors:  Erika M Milczek; Daniele Bonivento; Claudia Binda; Andrea Mattevi; Ian A McDonald; Dale E Edmondson
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

2.  Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors.

Authors:  Jeffrey C Culhane; Dongqing Wang; Paul M Yen; Philip A Cole
Journal:  J Am Chem Soc       Date:  2010-03-10       Impact factor: 15.419

3.  Allylamine cardiotoxicity: II. Histopathology and histochemistry.

Authors:  P J Boor; T J Nelson; P Chieco
Journal:  Am J Pathol       Date:  1980-09       Impact factor: 4.307

4.  Short-acting novel MAO inhibitors: in vitro evidence for the reversibility of MAO inhibition by moclobemide and Ro 16-6491.

Authors:  H H Keller; R Kettler; G Keller; M Da Prada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.